These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15919549)

  • 21. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment.
    Wang QS; Tian L; Huang YL; Qin S; He LQ; Zhou JN
    Brain Res; 2002 Sep; 951(1):77-81. PubMed ID: 12231459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
    Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
    Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of hormone therapy on olfactory sensitivity is dependent on apolipoprotein E genotype.
    Sundermann EE; Gilbert PE; Murphy C
    Horm Behav; 2008 Sep; 54(4):528-33. PubMed ID: 18620351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individuals at risk for Alzheimer's disease show differential patterns of ERP brain activation during odor identification.
    Morgan CD; Murphy C
    Behav Brain Funct; 2012 Jul; 8():37. PubMed ID: 22849610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ApoE gene and familial risk of Alzheimer's disease as predictors of odour identification in older adults.
    Handley OJ; Morrison CM; Miles C; Bayer AJ
    Neurobiol Aging; 2006 Oct; 27(10):1425-30. PubMed ID: 16202482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
    Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
    Qiu C; Winblad B; Fratiglioni L
    Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
    Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E epsilon4 positive individuals demonstrate delayed olfactory event-related potentials.
    Wetter S; Murphy C
    Neurobiol Aging; 2001; 22(3):439-47. PubMed ID: 11378251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Both odor identification and ApoE-ε4 contribute to normative cognitive aging.
    Finkel D; Reynolds CA; Larsson M; Gatz M; Pedersen NL
    Psychol Aging; 2011 Dec; 26(4):872-83. PubMed ID: 21517181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
    Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G
    Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOE epsilon4 is a high-risk factor for Alzheimer's disease in the Mongolian population.
    Huriletemuer ; Wang B; Wang J; Wang G; Zhang C; Zhao S; Zhou S; Ma X; Wang de S
    J Neurol Sci; 2010 Jan; 288(1-2):167-9. PubMed ID: 19819468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia.
    Olofsson JK; Nordin S; Wiens S; Hedner M; Nilsson LG; Larsson M
    Neurobiol Aging; 2010 Apr; 31(4):567-77. PubMed ID: 18619712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
    Suh GH; Jung HY; Lee CU; Oh BH; Lee SK; Lee N; Kim J; Kee BS; Ko D; Kim YH; Ju YS; Hong I; Choi S;
    Dement Geriatr Cogn Disord; 2006; 21(1):33-9. PubMed ID: 16254428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community.
    Devanand DP; Lee S; Manly J; Andrews H; Schupf N; Doty RL; Stern Y; Zahodne LB; Louis ED; Mayeux R
    Neurology; 2015 Jan; 84(2):182-9. PubMed ID: 25471394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease.
    Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Duara R
    Am J Geriatr Psychiatry; 1999; 7(2):119-23. PubMed ID: 10322238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.